Valeant Pharmaceuticals International Senior Developer Salaries in Peoria, IL
The average Valeant Pharmaceuticals International Senior Developer in Peoria, IL earns an estimated $111,202 annually, which includes an estimated base salary of $98,535 with a $12,667 bonus. Valeant Pharmaceuticals International's Senior Developer compensation is $26,393 less than the US average for a Senior Developer. Senior Developer salaries at Valeant Pharmaceuticals International in Peoria, IL can range from $100,000 - $118,000.
In Peoria, IL, The Engineering Department at Valeant Pharmaceuticals International earns $9,586 more on average than the Design Department.
Last updated 2 years ago.
- $98,535
- avg. base
- $12,667
- avg. bonus
Senior Developer Salaries at Valeant Pharmaceuticals International
In Peoria, IL, Senior Developers earn $98 more than Senior Developers, and $1,495 less than Senior QAs.
Compensation at Valeant Pharmaceuticals International by Department
In Peoria, IL, The Engineering Department averages $9,586 more than the Design Department, and $3,650 less than the Business Development Department
Senior Developer Compensation by Gender (All Companies)
The average female Senior Developer at companies similar size to Valeant Pharmaceuticals International reported making $146,554, while the average male Senior Developer at similar sized companies reported making $156,665.
Senior Developer Compensation by Ethnicity (All Companies)
The average Asian or Pacific Islander Senior Developer at companies similar size to Valeant Pharmaceuticals International reported making $153,064, while the average Native American Senior Developer at similar sized companies reported making $101,264.
How Senior Developers at Valeant Pharmaceuticals International Rate Their Compensation
The majority of Senior Developers at Valeant Pharmaceuticals International believe they're compensated fairly. The vast majority (80%) of Senior Developers at Valeant Pharmaceuticals International are satisfied with their benefits. See more compensation ratings at Valeant Pharmaceuticals International
